Synergistic effects were also obtained by combining BTK with either BCL2 inhibitors that enhance apoptosis or lenalidomide that increases toxic interferon responses in ABC DLBCL [10, 24]. The gene discussed is BCL2; the disease is aneurysmal bone cyst.